IHI collaborated with Jhpiego Pakistan to identify entry points to introduce DMPA-SC self-injection (SI) in Punjab’s commercial private sector, an untapped channel for FP access with the potential to move the needle on a stagnant modern contraceptive prevalence rate. The market systems development process resulted in a Pathway Report, which outlines a phased approach to the introduction of DMPA-SC in the private sector, including packaging considerations and potential subsidies to optimize market entry and pave the way for the future generic product.

In partnership with Jhpiego, IHI developed Country Roadmaps for the private sector provision of contraceptive implants in Kenya and Pakistan. Building off the global review from the 2022 project, this activity included conducting a literature review and key informant interviews and facilitation of in-country workshops and feedback webinars to inform a suite of strategic products, available here.

IHI collaborated with Jhpiego to (1) document the experience of Low and Middle-Income Countries (LMICs) successfully introducing contraceptive implants in the public sector over the last decade and (2) identify recommendations to scale up implants in the private sector. These insights were informed by a desk review, key informant interviews and virtual workshops, and resulted in a suite of resources for public use, available here.